There’s a lot of buzz about AI in the pharmaceutical industry, but it’s largely ... This, in turn, will create stiff competition at sites and for patients. The current way of conducting ...

The US pharmaceutical industry was booming ... as well as the science-boosting competition of the cold war. As the barriers to entry in drug production were raised, a great deal of consolidation ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Multinational pharmaceutical companies (MNCs) operating in China’s vaccine market face growing challenges as regulatory scrutiny, intensifying domestic competition, and shifting consumer ...